2013 annual financial data
Regeneron Pharmaceuticals 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was 27.97%.
Operating income was 760,028,000 USD and net income was 424,362,000 USD.
Operating cash flow was 588,596,000 USD.
Get free Regeneron Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,104,745,000 USD
- Operating income
- 760,028,000 USD
- Net income
- 424,362,000 USD
- Operating cash flow
- 588,596,000 USD